記憶度
15問
35問
0問
0問
0問
アカウント登録して、解答結果を保存しよう
問題一覧
1
Conducting Airways
Nose, Pharynx, Larynx, Trachea, Bronchi, Bronchioles
2
Extra-Thoracic
Nose, Pharynx, Larynx
3
Intrathoracic
Trachea, Bronchi, Bronchioles
4
Respiratory Zone
Terminal Bronchi, Alveoli, Aveolar Capillaries
5
Keeps smooth muscle areas open
Transpulmonary Pressures
6
Factors that relax smooth muscles in bronchi and bronchioles
Sympathetic (Beta-2 and Epi)
7
Contraction of bronchiolar smooth muscle and bronchoconstriction
Parasympathetic from vagas nerve releasing acetylcholine
8
Contraction of bronchiolar smooth muscle and bronchoconstriction
Release of leukotrines and histamine from lung cells and endothelium
9
Contraction of bronchiolar smooth muscle and bronchoconstriction
Histamine released from mast cells
10
Small changes in diameter increases difficulty of breathing
Airway Resistance
11
Increases suction pulling lungs with ribs (normally -5, when chest expands decreases to -7.5)
Pleural Pressure
12
Measure pressure of respiratory tree when glottis is open = atmospheric pressure (0 cm H2O)
Alveolar Pressure
13
Alveolar Pressure
Chest expansion (-1) air moves in. Chest recoil (+1) air moves out.
14
Difference between pleural and alveolar pressures
Transpulmonary Pressure
15
Elastic forces that cause lung collapse at end of exhalation are counteracted by PEEP, surfactant, and closed glottis
Transpulmonary Pressure
16
Breach of pleural spaces, air gets trapped, lung can’t expand because pleural space becomes equivalent to alveolar/atmospheric pressure (change from -4 to 0 mmHg)
Pneumothorax
17
Patient comes in to the clinic with dyspnea, tachycardia, deviated trachea, decreased breath sounds on affected side, hyperresonance to percussion.
Pneumothorax
18
Increased Resistance Curve
Asthma and COPD
19
Decreased Compliance Curve
PNE and Pulmonary Edema
20
Channels between alveoli to allow communication. Implicated in alveolar diseases and ease of spread of pulmonary infections.
Pores of Kohn and Canal of Lambert
21
Coats inner alveoli and allows expansion during inhalation and prevents alveolar collapse on exhalation.
Surfactant
22
Contraction pulls lungs down during inhalation and relaxation/elastic recoil moves lungs up during exhalation
Diaphram
23
Raise and expand rib cage with help of sternocleidomastoid muscles on inhalation
External intercostals
24
Pulls rib cage down and in during exhalation
Internal intercostals and abdominal recti
25
Tissue lining the lungs and rib cage
Pleura
26
Tissue lining the lungs
Visceral Pleura
27
Tissue lining the rib cage
Parietal Pleura
28
Fills the space between the visceral and parietal pleura
Pleural fluid
29
Degree lungs expand per unit of change in transpulmonary pressure and determined by elastic forces in lung tissue, alveoli, lung interstitum, and pleural tension
Lung compliance
30
Air-fluid interface creates a force that causes the alveoli to collapse inward
Surface tension elastic force
31
Alveoli are lined with small amounts of fluid - water molecules of alveolar fluid are attracted to water molecules in the air
Contractile force
32
Reduces the surface tension and disrupts the water molecules
Surfactant
33
There is greater muscular effort needed to expand the thorax and chest wall has limited recoil
Rigidity of mature rib cage
34
The chest wall is less rigid and easier to expand but has strong recoil and more potential for collapse during exhalation
Cartilaginous ribs of children
35
Lung compliance is decreased with
Pulmonary edema or infection
36
Chest wall compliance is decreased
Scoliosis and obesity
37
Airways are obstructed
Bronchospasm or mucous plugging
38
Volume of inspired and expired air with each breath
Tidal volume
39
Maxium extra volume of air that can be inspired at the end of a normal volume
Inspiratory reserve volume
40
Maximum extra volume of air that can be expired at the end of a normal tidal volume
Expiratory reserve volume
41
Tidal volume + Inspiratory reserve volume
Inspiratory capacity
42
Expiratory reserve volume + residual volume (amount of air that remains at the end of normal exhalation)
Functional residual capacity
43
Inspiratory reserve volume + tidal volume + expiratory reserve volume (maximum volume that can be exhaled after maximum inhale)
Vital capacity
44
Vital capacity + residual volume (maximum volume lung can be expanded)
Total lung capacity
45
Tidal volume x respiratory rate
Minute ventilation
46
The rate air reaches the gas-exchange areas of the lungs via diffusion
Alveolar ventilation
47
Space in respiratory system where no gas exchange occurs (alveoli without blood flow)
Dead space
48
Anatomic dead space + alveoli without blood flow
Physiologic dead space
49
Conducting zones = 30% of total lung capacity
Anatomic dead space
50
Causes CO2 trapping
Dead spaces
51
Anatomy of Pulmonary Circulation
RV—>Pulmonary Artery—>Pulmonary Capillary Bed—>Pulmonary Vein—>LA
52
From systemic circulation, provide oxygenated blood to trachea, bronchi, esophagus, visceral pleural and pulmonary arteries but doesn’t contribute to gas exchange
Bronchial vessels
53
Balance between alveolar ventilation and alveolar blood flow
V/Q matching
54
When V/Q mismatched there will be differences between
Alveolar O2 and PaO2, ETCO2 and PaCO2
55
PaO2 will be normal if
Patient has lung disease and intact V/Q because body has shunted blood to alveoli that are perfused
56
V/Q is below normal = inadequate ventilation to oxygenate blood flowing through alveolar capillaries. Inability to shunt blood to alveoli that are perfused.
Physiologic shunting
57
V/Q is above normal = alveoli are well ventilated but there are alveoli that are not well perfused. Something is blocking blood flow to these alveoli.
Physiologic dead space
58
No blood flow (capillary pressure < alveolar pressure)
Zone I
59
Intermittent blood flow (with peak pulmonary capillary pressure > alveolar pressure…diastolic capillary pressure < alveolar pressure)
Zone II
60
Continuous blood blow (capillary pressure > alveolar pressure)
Zone III
61
Blood flow occurs when PA pressures are too high (R HF or RVOT obstruction) or alveolar pressure too high (hyperinflation)
Zone I
62
During exercise (increased CO) all areas of lungs get
Zone III
63
Pressure in pulmonary capillaries
Low, 7mmHg
64
Interstitial fluid pressures
Negative, -5 to -8 mmHg
65
Net fluid movement from alveoli to interstitial space —> drains into lymphatics (keeps alveoli free of excess fluid)
Mean filtration pressure
66
Excess fluid in the alveoli impairing gas exchange and decreasing lung compliance
Pulmonary edema
67
Increased left heart pressures, pulmonary over-circulation, increased pulmonary capillary permeability (inflammation)
Causes of pulmonary edema
68
Mucoid fluid in the pleural space that contributes to negative intrapleural pressure that prevents pulmonary edema
Pleural fluid
69
Excess fluid in pleural space
Pleural effusion
70
Blocked lymph drainage, LHF, Reduced Plasma Oncotic Pressure (causes increased fluid accumulation), Increased Permeability Membrane (inflammation)
Causes of Pleural Effusion
71
Normal SpO2 range
97-100%
72
SvO2 normal range
75%
73
CO2 is bound to hemoglobin and transported (Carboxyhemoglobin), transport is bicarbonate, combines with blood protein (carbamino compounds), oxygen in alveoli displaces CO2 on Hbg promoting CO2 removal (Haldane effect) and ventilated out of the body
CO2 Transport
74
Groups of Medulla
Dorsal and Ventral
75
Brain stem center controls Inspiration
Dorsal
76
Brain stem center controls exhalation
Ventral
77
Pneumotaxic center - controls breathing rate and pattern
Pons
78
Vagal and glossopharyngeal nerves end in the medulla. Transmit signals from chemoreceptors and baroreceptors. Send signals to diaphram and intercostal muscles to controls rate of breathing and inspiration time
Dorsal respiratory neurons
79
Inactive during normal breathing, fire during hypoventilation and signal inspiration, stimulate abdominal muscle contraction for forceful exhalation
Ventral respiratory neurons
80
Neurons in medulla, sense changes in pH of CSF, mechanism detects small changes in CO2 (1-2 mmHg), changes rate and depth and respirations
Central Chemoreceptors
81
Chronic condition that can make central chemoreceptors less sensitive by increasing bicarbonate
COPD
82
This molecule crosses BBB to combine with H2O to create bicarbonate
CO2
83
Chemoreceptors in carotid and aortic bodies that sense changes in O2 concentration. Decreased PaO2 levels will increase respiratory rate.
Peripheral chemoreceptors
84
Found in epithelium of conducting airways, sensitive to aerosols, gases, particles (induces cough) increases respiratory rate and can lead to Bronchospasm
Irritation receptors
85
When smooth muscle in bronchi, bronchioles, or lung parenchyma stretched —> signal medulla dorsal respiratory neurons to switch off Inspiration (Hering-Breuer Inflation Reflex)
Stretch receptors
86
Respond to increased pulmonary capillary pressures (eg LHF) —> initiate rapid, shallow breathing, causes laryngeal vasoconstriction and mucous secretion
Pulmonary C-Receptors (J receptors)
87
Vasoconstriction to area of lung, decreased surfactant, high V/Q mismatch. Diagnosis - tachypnea, dyspnea, chest pain, hypoxia, pulmonary edema and atelectasis, pulmonary infarct and pulmonary HTN, decreased CO, elevated D-dimer (early test), CTA or MRA tests (confirm diagnosis), EKG changes with right strain, troponin level to help stratify risk of adverse outcomes. Treatment- fibrinolytics
Pulmonary embolism
88
Pulmonary artery pressure > 25 mmHg, associated with chronic hypoxia, LHF, valve disease causing dyspnea, chest pain,tachypnea, cough, JVD
PAH
89
Causes (idiopathic, genetic, connective tissue disease). Pathophysiology (vasoconstrictors overwhelm pulmonary vasodilators —> resistance of blood flow to lungs —> RV remodeling —> Cor Pulmonale (RHF)
Pulmonary Artery Hypertension
90
Hallmarks: Worse on expiration —> prolonged expiratory phase and decreased FEV. Dyspnea. Wheezing (lower airways) and Stridor (upper airways)
Obstructive Lung Disease
91
Chronic inflammatory disease of bronchial mucosa causing hyperresponsiveness, bronchoconstriction, and obstruction
Asthma
92
Antigen exposure —> cytokine response —> increased capillary permeability, mucosal edema and production, Bronchospasm
Early Asthma Response
93
Inflammatory mediators —> Bronchospasm —> secretions —> obstruction—> air trapping —> hyperinflation —> V/Q mismatch —> hypoxemia —> CO2 retention —> acidosis —> respiratory failure
Late Response Asthma
94
Treatment: Beta2 (albuterol), Anticholinergics, Steroids, and Antihistamines
Asthma
95
Airflow obstruction that is not fully reversible and generally progressive. Generally, “acquired” but some genetic basis (alpha1-anti-trypsin deficiency)
COPD
96
Hypersecretion of mucus and chronic productive cough (3months/yr for 2+ yrs). Initially impacts large airways but ultimately affects all bronchial smooth muscle. Bronchial inflammation—> edema—> increased size and number of mucosal cells and goblet cells—> air trapping on expiration. V/Q mismatch—> hypoxemia—>mild cyanosis. Dyspnea on exertion. Chronic hypercarbia.
Chronic Bronchitis
97
Enlargement of respiratory airways and destruction of alveolar zones. Breakdown of elastin —> loss of elastic recoil —> air trapping —> dyspnea —> hypoventilation —> hypercarbia. Structural changes (loss of alveolar cells) —> increased area for gas exchange + bullae and blebs —> V/Q mismatch —> hypoxemia. Systemic effects of chronic inflammation —> malnutrition and infection risk
Emphysema
98
Productive cough (classic sign), dyspnea (late in course), wheezing (intermittent), barrel chest (occasionally), prolonged exhalation (always), Cyanosis (common), chronic hypoventilation (common), Cor Pulmonale (common)
Chronic Bronchitis
99
Productive cough (late in course), dyspnea (common), wheezing (minimal), barrel chest (classic sign), prolonged exhalation (always), Cyanosis (uncommon), chronic hypoventilation (late in course), Cor Pulmonale (late in course)
Emphysema
100
Caused from acute viral infection. Subglottic edema causes narrowing of airway and respiratory distress develops into barky cough and stridor
Croup